SEARCH

SEARCH BY CITATION

References

  • Addabbo F., Montagnani M. and Goligorsky M. S. (2009) Mitochondria and reactive oxygen species. Hypertension 53, 885892.
  • Alessandrini A., Namura S., Moskowitz M. A. and Bonventre J. V. (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl Acad. Sci. USA 96, 1286612869.
  • Bal-Price A. and Brown G. C. (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21, 64806491.
  • Boison D., Chen J. F. and Fredholm B. B. (2010) Adenosine signaling and function in glial cells. Cell Death Differ. 17, 10711082.
  • Bonde C., Sarup A., Schousboe A., Gegelashvili G., Zimmer J. and Noraberg J. (2003) Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions. Neurochem. Int. 43, 371380.
  • Brown G. C. (2010) Nitric oxide and neuronal death. Nitric Oxide 23, 153165.
  • Cárdenas A., De Alba J., Moro M. A., Leza J. C., Lorenzo P. and Lizasoain I. (1998) Protective effect of N-(3-(aminomethyl)benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation. Eur. J. Pharmacol. 354, 161165.
  • Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623634.
  • Christophe M. and Nicolas S. (2006) Mitochondria: a target for neuroprotective interventions in cerebral ischemia-reperfusion. Curr. Pharm. Des. 12, 739757.
  • Ciccarelli R., Di Iorio P., Giuliani P., D'Alimonte I., Ballerini P., Caciagli F. and Rathbone M. P. (1999) Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25, 9398.
  • Ciccarelli R., Di Iorio P., D'Alimonte I., Giuliani P., Florio T., Caciagli F., Middlemiss P. J. and Rathbone M. P. (2000) Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. Glia 29, 202211.
  • Ciccarelli R., Ballerini P., Sabatino G., Rathbone M. P., D'Onofrio M., Caciagli F. and Di Iorio P. (2001) Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci. 19, 395414.
  • Ciccarelli R., D'Alimonte I., Ballerini P., D'Auro M., Nargi E., Buccella S., Di Iorio P., Bruno V., Nicoletti F. and Caciagli F. (2007) Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes. Mol. Pharmacol. 71, 13691380.
  • Ciruela F., Casado V., Rodrigues R. J. et al. (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci. 26, 20802087.
  • Ciruela F., Fernández-Dueñas V., Llorente J., Borroto-Escuela D., Cuffí M. L., Carbonell L., Sánchez S., Agnati L. F., Fuxe K. and Tasca C. I. (2012) G protein-coupled receptor oligomerization and brain integration: Focus on adenosinergic transmission. Brain Res. 1476, 8695.
  • Cristóvão-Ferreira S., Navarro G., Brugarolas M. et al. (2011) Modulation of GABA transport by adenosine A1R-A2AR heteromers, which are coupled to both Gs- and G(i/o)-proteins. J. Neurosci. 31, 1562915639.
  • Cunha R. A. (2005) Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal. 1, 111134.
  • Dal-Cim T., Martins W. C., Santos A. R. and Tasca C. I. (2011) Guanosine is neuroprotective against oxygen/glucose deprivation in hippocampal slices via large conductance Ca(2)+-activated K+ channels, phosphatidilinositol-3 kinase/protein kinase B pathway activation and glutamate uptake. Neuroscience 183, 212220.
  • Dal-Cim T., Molz S., Egea J., Parada E., Romero A., Budni J., Martín de Saavedra M. D., del Barrio L., Tasca C. I. and López M. G. (2012) Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3beta pathway. Neurochem. Int. 63, 397404.
  • D'Alimonte I., Flati V., D'Auro Toniato E., Martinotti S., Rathbone M. P., Jiang S., Ballerini P., Di Iorio P., Caciagli F. and Ciccarelli R. (2007) Guanosine inhibits CD40 receptor expression and function induced by cytokines and beta amyloid in mouse microglia cells. J. Immunol. 178, 720731.
  • Danbolt N. C. (2001) Glutamate uptake. Prog. Neurobiol. 65, 1105.
  • Di Iorio P., Ballerini P., Traversa U., Nicoletti F., D'Alimonte I., Kleywegt S., Werstiuk E. S., Rathbone M. P., Caciagli F. and Ciccarelli R. (2004) The antiapoptotic effect of guanosine is mediated by the activation of the PI 3-kinase/AKT/PKB pathway in cultured rat astrocytes. Glia 46, 356368.
  • Egea J., Rosa A. O., Cuadrado A., Garcia A. G. and Lopez M. G. (2007) Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress. J. Neurochem. 102, 18421852.
  • Espada S., Ortega F., Molina-Jijon E., Rojo A. I., Perez-Sen R., Pedraza-Chaverri J., Miras-Portugal M. T. and Cuadrado A. (2010) The purinergic P2Y(13) receptor activates the Nrf2/HO-1 axis and protects against oxidative stress-induced neuronal death. Free Radic. Biol. Med. 49, 416426.
  • Frizzo M. E., Frizzo J. K., Amadio S., Rodrigues J. M., Perry M. L., Bernardi G. and Volonte C. (2007) Extracellular adenosine triphosphate induces glutamate transporter-1 expression in hippocampus. Hippocampus 17, 305315.
  • Gloire G., Legrand-Poels S. and Piette J. (2006) NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72, 14931505.
  • Gomes C. V., Kaster M. P., Tome A. R., Agostinho P. M. and Cunha R. A. (2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim. Biophys. Acta 1808, 13801399.
  • Gysbers J. W., Guarnieri S., Mariggio M. A., Pietrangelo T., Fano G. and Rathbone M. P. (2000) Extracellular guanosine 5′ triphosphate enhances nerve growth factor-induced neurite outgrowth via increases in intracellular calcium. Neuroscience 96, 817824.
  • Iadecola C. and Ross M. E. (1997) Molecular pathology of cerebral ischemia: delayed gene expression and strategies for neuroprotection. Ann. N. Y. Acad. Sci. 835, 203217.
  • Jacobson K. A. and Gao Z. G. (2006) Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discovery 5, 247264.
  • Kirino T. and Sano K. (1984) Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol. 62, 201208.
  • Li L. B., Toan S. V., Zelenaia O., Watson D. J., Wolfe J. H., Rothstein J. D. and Robinson M. B. (2006) Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J. Neurochem. 97, 759771.
  • Liu Y., Peterson D. A., Kimura H. and Schubert D. (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69, 581593.
  • Maddahi A., Ansar S., Chen Q. and Edvinsson L. (2011) Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model. J. Cereb. Blood Flow Metab. 31, 144154.
  • Madrigal J. L., Garcia-Bueno B., Caso J. R., Perez-Nievas B. G. and Leza J. C. (2006) Stress-induced oxidative changes in brain. CNS Neurol. Disord. Drug Targets 5, 561568.
  • Martin-de-Saavedra M. D., del Barrio L., Canas N., Egea J., Lorrio S., Montell E., Verges J., Garcia A. G. and Lopez M. G. (2011) Chondroitin sulfate reduces cell death of rat hippocampal slices subjected to oxygen and glucose deprivation by inhibiting p38, NFkappaB and iNOS. Neurochem. Int. 58, 676683.
  • Matos M., Augusto E., Santos-Rodrigues A. D., Schwarzschild M. A., Chen J. F., Cunha R. A. and Agostinho P. (2012) Adenosine A(2A) receptors modulate glutamate uptake in cultured astrocytes and gliosomes. Glia 60, 702716.
  • Mattson M. P., Culmsee C., Yu Z. and Camandola S. (2000) Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74, 443456.
  • Molz S., Dal-Cim T. and Tasca C. I. (2009) Guanosine-5′-monophosphate induces cell death in rat hippocampal slices via ionotropic glutamate receptors activation and glutamate uptake inhibition. Neurochem. Int. 55, 703709.
  • Molz S., Dal-Cim T., Budni J. et al. (2011) Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase 3beta pathway activation and inducible nitric oxide synthase inhibition. J. Neurosci. Res. 89, 14001408.
  • Moretto M. B., Arteni N. S., Lavinsky D., Netto C. A., Rocha J. B., Souza D. O. and Wofchuk S. (2005) Hypoxic-ischemic insult decreases glutamate uptake by hippocampal slices from neonatal rats: prevention by guanosine. Exp. Neurol. 195, 400406.
  • Moro M. A., Cardenas A., Hurtado O., Leza J. C. and Lizasoain I. (2004) Role of nitric oxide after brain ischaemia. Cell Calcium 36, 265275.
  • Muller C. E. and Scior T. (1993) Adenosine receptors and their modulators. Pharm. Acta Helv. 68, 77111.
  • Murphy A. N., Fiskum G. and Beal M. F. (1999) Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J. Cereb. Blood Flow Metab. 19, 231245.
  • Oleskovicz S. P., Martins W. C., Leal R. B. and Tasca C. I. (2008) Mechanism of guanosine-induced neuroprotection in rat hippocampal slices submitted to oxygen-glucose deprivation. Neurochem. Int. 52, 411418.
  • Oliveira D. L., Horn J. F., Rodrigues J. M., Frizzo M. E., Moriguchi E., Souza D. O. and Wofchuk S. (2004) Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine. Brain Res. 1018, 4854.
  • Quarta D., Ferre S., Solinas M., You Z. B., Hockemeyer J., Popoli P. and Goldberg S. R. (2004) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J. Neurochem. 88, 11511158.
  • Pocock J. M. and Nicholls D. G. (1998) Exocytotic and nonexocytotic models of glutamate release from cultured cerebellar granule cells during chemical ischemia. J. Neurochem. 70, 806813.
  • Rathbone M. P., Saleh T. M., Connell B. J., Chang R., Su C., Worley B. and Kim   and Jiang S. (2011) Systemic administration of guanosine promotes functional and histological improvement following an ischemic stroke in rats. Brain Res. 1407, 7989.
  • Rojo A. I., Salina M., Salazar M., Takahashi S., Suske G., Calvo V., de Sagarra M. R. and Cuadrado A. (2006) Regulation of heme oxygenase-1 gene expression through the phosphatidylinositol 3-kinase/PKC-zeta pathway and Sp1. Free Radic. Biol. Med. 41, 247261.
  • Schmidt A. P., Lara D. R., Faria Maraschin J., Silveira Perla A. and Souza D. (2000) Guanosine and GMP prevent seizures induced by quinolinic acid in mice. Brain Res. 864, 4043.
  • Schmidt A. P., Lara D. R. and Souza D. O. (2007) Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol. Ther. 116, 401416.
  • Sethi G., Sung B. and Aggarwal B. B. (2008) Nuclear factor-kappaB activation: from bench to bedside. Exp. Biol. Med. (Maywood) 233, 2131.
  • Sperlagh B. and Vizi E. S. (2011) The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects. Curr. Top. Med. Chem. 11, 10341046.
  • Sperlágh B., Zsilla G., Baranyi M., Illes P. and Vizi E. S. (2007) Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus. Neuroscience 149, 99111.
  • Stanika R. I., Winters C. A., Pivovarova N. B. and Andrews S. B. (2010) Differential NMDA receptor-dependent calcium loading and mitochondrial dysfunction in CA1 vs. CA3 hippocampal neurons. Neurobiol. Dis. 37, 403411.
  • Tasca C. I., Burgos J. S., Barat A., Souza D. O. and Ramirez G. (1999) Chick kainate binding protein lacks GTPase activity. NeuroReport 10, 19811983.
  • Tasca C. I., Dal-Cim T., Parada E., Egea J. and Lopez M. G. (2011) Guanosine is neuroprotective against oxygen/glucose deprivation: modulation of oxidative stress via A1R,MAPK, NF-κB, iNOS pathway. J. Neurochem. 118 (Suppl. 1 WE06-15), 165244.
  • Thauerer B., zur Nedden S. and Baier-Bitterlich G. (2010) Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia. J. Neurochem. 113, 432446.
  • Thauerer B., Zur Nedden S. and Baier-Bitterlich G. (2012) Purine nucleosides: endogenous neuroprotectants in hypoxic brain. J. Neurochem. 121, 329342.
  • Tomaselli B., Nedden S. Z., Podhraski V. and Baier-Bitterlich G. (2008) p42/44 MAPK is an essential effector for purine nucleoside-mediated neuroprotection of hypoxic PC12 cells and primary cerebellar granule neurons. Mol. Cell. Neurosci. 38, 559568.
  • Traversa U., Bombi G., Di Iorio P., Ciccarelli R., Werstiuk E. S. and Rathbone M. P. (2002) Specific [(3)H]-guanosine binding sites in rat brain membranes. Br. J. Pharmacol. 135, 969976.
  • Trotti D., Danbolt N. C. and Volterra A. (1998) Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol. Sci. 19, 328334.
  • Volpini R., Marucci G., Buccioni M., Dal Ben D., Lambertucci C., Lammi C., Mishra R. C., Thomas A. and Cristalli G. (2011) Evidence for the existence of a specific g protein-coupled receptor activated by guanosine. ChemMedChem 6, 10741080.
  • Yuan L., Wang J., Xiao H., Xiao C., Wang Y. and andLiu X. (2012) Isoorientin induces apoptosis through mitochondrial dysfunction and inhibition of PI3K/Akt signaling pathway in HepG2 cancer cells. Toxicol. Appl. Pharmacol. 265, 8392.
  • Zhang W., Potrovita I., Tarabin V., Herrmann O., Beer V., Weih F., Schneider A. and Schwaninger M. (2005) Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 25, 3040.